Oxygen Biotherapeutics (OXBT) Widens Q4 Loss of 26c/Share

Oxygen Biotherapeutics (NASDAQ: OXBT) reported Q4 EPS of ($0.26), versus ($0.11) reported last year. Revenue for the quarter came in at $148.26 thousand, versus $26.59 thousand reported last year.

For earnings history and earnings-related data on Oxygen Biotherapeutics (OXBT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
• EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance